A case of recurrent lip cancer with middle skull base invasion with response to cetuximab and paclitaxel combination chemotherapy after nivolumab monotherapy
暂无分享,去创建一个
[1] C. Dinh,et al. Molecular and Cellular Mechanisms of Perineural Invasion in Oral Squamous Cell Carcinoma: Potential Targets for Therapeutic Intervention , 2021, Cancers.
[2] C. Moscheni,et al. Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) know , 2020, Journal of experimental & clinical cancer research : CR.
[3] Y. Nishimura,et al. Safety and efficacy of cetuximab-containing chemotherapy after immune checkpoint inhibitors for patients with squamous cell carcinoma of the head and neck: a single-center retrospective study , 2020, Anti-cancer drugs.
[4] Hideaki Takahashi,et al. Salvage Chemotherapy After Nivolumab for Recurrent or Metastatic Head and Neck Carcinoma , 2020, AntiCancer Research.
[5] L. Zitvogel,et al. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors , 2020, Nature Reviews Clinical Oncology.
[6] R. Uchi,et al. Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma , 2020, Cancers.
[7] Y. Kawasaki,et al. Efficacy of chemotherapy after progression with nivolumab in squamous cell carcinoma of the head and neck. , 2020, Auris, nasus, larynx.
[8] Jason M. Johnson,et al. Response rates and survival to systemic therapy after immune checkpoint inhibitor failure in recurrent/metastatic head and neck squamous cell carcinoma. , 2019, Oral oncology.
[9] F. Bidault,et al. Response to salvage chemotherapy after progression on immune checkpoint inhibitors in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. , 2019, European journal of cancer.
[10] K. Harrington,et al. Nivolumab in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Efficacy and Safety in CheckMate 141 by Prior Cetuximab Use , 2019, Clinical Cancer Research.
[11] G. Freeman,et al. Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer. , 2016, Cancer research.
[12] K. Ikenberg,et al. Perineural Invasion in Squamous Cell Carcinoma of the Oral Cavity: Histology, Tumor Stage, and Outcome , 2016, Laryngoscope investigative otolaryngology.
[13] L. Galluzzi,et al. Organelle-specific initiation of cell death , 2014, Nature Cell Biology.
[14] B. Panizza,et al. Perineural Invasion of Head and Neck Skin Cancer: Diagnostic and Therapeutic Implications , 2013, Current Oncology Reports.
[15] J. Taube,et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] S. Shingaki,et al. Prognostic significance of perineural invasion in oral and oropharyngeal carcinoma. , 2004, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[17] Li-xi Yang,et al. The immunological effects of taxanes , 2000, Cancer Immunology, Immunotherapy.
[18] N. Kurumatani,et al. Descriptive epidemiology of oral cancer in Japan , 1997 .
[19] S. Stringer,et al. Carcinoma of the skin of the head and neck with perineural invasion , 1989, Head & neck.
[20] J. Trobe,et al. Intracranial spread of squamous carcinoma along the trigeminal nerve. , 1982, Archives of ophthalmology.
[21] S. Kikuta,et al. A case of recurrent oral cancer treated with interchangeable administrations of immune checkpoint inhibitors and chemotherapy agents , 2021, Journal of Japanese Society of Oral Oncology.
[22] K. Okami,et al. Clinical Study on recurrent and metastatic head and neck cancer patients treated with Nivolumab , 2020 .
[23] H. Ojiri. Perineural spread in head and neck malignancies , 2006, Radiation Medicine.
[24] Dr. E. Neumann. Secundäre Cancroidinfiltration des Nervus mentalis bei einem Fall von Lippencancroid , 2005, Archiv für pathologische Anatomie und Physiologie und für klinische Medicin.